Hypereosinophilic Syndrome Variants: Diagnostic and Therapeutic Considerations

Overview

Journal Haematologica

Specialty Hematology

Date 2009 Sep 8

PMID 19734412

Citations 23

Authors

Florence Roufosse

Affiliations

Soon will be listed here.

Citing Articles

Unexpected Multiple Gastrointestinal Cancers in a Patient with Chronic Eosinophilia: A Case Report.

Xie W, Hong B, Hu C, Luan F, Gong W J Gastrointest Cancer. 2024; 56(1):18.

PMID: 39538031 DOI: 10.1007/s12029-024-01134-3.

B-cell acute lymphoblastic leukemia associated with hypereosinophilia: a case report and brief literature review.

Khosravi S, Mousavi-Fatemi K, Ebrahimi P, Barary M, Sio T, Tavakoli Pirzaman A SAGE Open Med Case Rep. 2024; 12:2050313X241229592.

PMID: 38304855 PMC: 10832437. DOI: 10.1177/2050313X241229592.

Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes.

Valent P, Klion A, Roufosse F, Simon D, Metzgeroth G, Leiferman K Allergy. 2022; 78(1):47-59.

PMID: 36207764 PMC: 9797433. DOI: 10.1111/all.15544.

A Diagnosis of Idiopathic Hypereosinophilic Syndrome With Skin Involvement in a Patient Presenting With Lymphadenopathy and Rash.

Sekar N, Umakanth M Cureus. 2022; 14(3):e23580.

PMID: 35494909 PMC: 9045841. DOI: 10.7759/cureus.23580.

Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes.

Stella S, Massimino M, Manzella L, Pennisi M, Tirro E, Romano C Int J Mol Sci. 2021; 22(2).

PMID: 33418988 PMC: 7825323. DOI: 10.3390/ijms22020486.

References

Cogan E, Schandene L, Crusiaux A, Cochaux P, Velu T, Goldman M . Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med. 1994; 330(8):535-8. DOI: 10.1056/NEJM199402243300804. View

Rothenberg M, Klion A, Roufosse F, Kahn J, Weller P, Simon H . Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med. 2008; 358(12):1215-28. DOI: 10.1056/NEJMoa070812. View

Metzgeroth G, Walz C, Score J, Siebert R, Schnittger S, Haferlach C . Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma. Leukemia. 2007; 21(6):1183-8. DOI: 10.1038/sj.leu.2404662. View

de Lavareille A, Roufosse F, Schandene L, Stordeur P, Cogan E, Goldman M . Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivo. Eur J Immunol. 2001; 31(4):1037-46. DOI: 10.1002/1521-4141(200104)31:4<1037::aid-immu1037>3.0.co;2-#. View

Simon H, Plotz S, Dummer R, Blaser K . Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med. 1999; 341(15):1112-20. DOI: 10.1056/NEJM199910073411503. View

Roufosse F, Cogan E, Goldman M . Lymphocytic variant hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007; 27(3):389-413. DOI: 10.1016/j.iac.2007.07.002. View

Pardanani A, Brockman S, Paternoster S, Flynn H, Ketterling R, Lasho T . FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood. 2004; 104(10):3038-45. DOI: 10.1182/blood-2004-03-0787. View

Ravoet M, Sibille C, Gu C, Libin M, Haibe-Kains B, Sotiriou C . Molecular profiling of CD3-CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways. Blood. 2009; 114(14):2969-83. DOI: 10.1182/blood-2008-08-175091. View

McPherson T, Cowen E, McBurney E, Klion A . Platelet-derived growth factor receptor-alpha-associated hypereosinophilic syndrome and lymphomatoid papulosis. Br J Dermatol. 2006; 155(4):824-6. DOI: 10.1111/j.1365-2133.2006.07416.x. View

10.

Griffin J, Leung J, Bruner R, Caligiuri M, Briesewitz R . Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proc Natl Acad Sci U S A. 2003; 100(13):7830-5. PMC: 164673. DOI: 10.1073/pnas.0932698100. View

11.

Bergua J, Prieto-Pliego E, Roman-Barbera A, Garcia-Toron J, Gomez-Barrado J, Marcos G . Resolution of left and right ventricular thrombosis secondary to hypereosinophilic syndrome (lymphoproliferative variant) with reduced intensity conditioning allogenic stem cell transplantation. Ann Hematol. 2008; 87(11):937-8. DOI: 10.1007/s00277-008-0505-9. View

12.

Galimberti S, Ciabatti E, Ottimo F, Rossi A, Trombi L, Carulli G . Cell clonality in hypereosinophilic syndrome: what pathogenetic role?. Clin Exp Rheumatol. 2007; 25(1):17-22. View

13.

Metzgeroth G, Walz C, Erben P, Popp H, Schmitt-Graeff A, Haferlach C . Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: a phase-II study. Br J Haematol. 2008; 143(5):707-15. DOI: 10.1111/j.1365-2141.2008.07294.x. View

14.

Simon H, Yousefi S, Zimmermann D, Bauer S, Barandun J, Blaser K . Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med. 1996; 183(3):1071-82. PMC: 2192315. DOI: 10.1084/jem.183.3.1071. View

15.

Roufosse F, Schandene L, Sibille C, Willard-Gallo K, Kennes B, Efira A . Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. Br J Haematol. 2000; 109(3):540-8. DOI: 10.1046/j.1365-2141.2000.02097.x. View

16.

Vaklavas C, Tefferi A, Butterfield J, Ketterling R, Verstovsek S, Kantarjian H . 'Idiopathic' eosinophilia with an Occult T-cell clone: prevalence and clinical course. Leuk Res. 2006; 31(5):691-4. DOI: 10.1016/j.leukres.2006.10.005. View

17.

Cools J, DeAngelo D, Gotlib J, Stover E, Legare R, Cortes J . A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003; 348(13):1201-14. DOI: 10.1056/NEJMoa025217. View

18.

Ravoet M, Sibille C, Roufosse F, Duvillier H, Sotiriou C, Schandene L . 6q- is an early and persistent chromosomal aberration in CD3-CD4+ T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome. Haematologica. 2005; 90(6):753-65. View

19.

Chusid M, Dale D, West B, Wolff S . The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore). 1975; 54(1):1-27. View

20.

Willard-Gallo K, Badran B, Ravoet M, Zerghe A, Burny A, Martiat P . Defective CD3gamma gene transcription is associated with NFATc2 overexpression in the lymphocytic variant of hypereosinophilic syndrome. Exp Hematol. 2005; 33(10):1147-59. DOI: 10.1016/j.exphem.2005.06.027. View